Effect of cetirizine on human eosinophil superoxide generation, eosinophil chemotaxis and eosinophil peroxidase in vitro

International Archives of Allergy and Immunology

Volumn 103, Issue 4, 1994, Pages 384-390

  Okada, Chiharu ^a   Eda, Ryosuke ^a   Miyagawa, Hidefumi ^a   Sugiyama, Haruhito ^a   Hopp, Russell J ^a   Bewtra, Againdra K ^a   Townley, Robert G ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

Allergy; Antihistamine; Cetirizine; Chemotaxis; Eosinophils

Indexed keywords

CETIRIZINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PEROXIDASE; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

ADULT; CETIRIZINE; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; FEMALE; HUMAN; HYPERSENSITIVITY; MALE; MIDDLE AGE; PEROXIDASES; PLATELET ACTIVATING FACTOR; SUPEROXIDES; SUPPORT, NON-U.S. GOV'T;

EID: 0028295046     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000236658     Document Type: Article

References (27)

1. Snyder SH. Snowman AM: Receptor effects of cetirizine. Ann Allergy 1987:59:4-8.
2. De Vos C, Maleux MR, Baltes E, Gobert J: Inhibition of histamine and allergen skin wheal by cetirizine in four animal species. Ann Allergy 1987:59:278-282.
3. Pechadre JC, Vernay D, Trolese JF, Bloom M, Dupont P, Rihoux JP: Comparison of the central and peripheral effects of cetirizine and terfenadine. Eur J Clin Pharmacol 1988:35:255-259.
4. Juhlin L. Rihoux JP: Effect of cetirizine on cutaneous reactions to PAF. kallikrein and serum in patients with chronic urticaria. Acta Derm Venereol (Stockh) 1990:70:151-153.
5. Broide DH. Love S. Altman R. Wasserman SI: Evaluation of cetirizine in the treatment of patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1988:81:176.
6. Brik A. Tashkin DP, Gong H. Dauphincc B, Lee E: Effect of cetirizine. a new histamine H1 antagonist, on airway dynamics and responsiveness to inhaled histamine in mild asthma. J Allergy Clin Immunol 1987:80:51-56.
7. Fadel R. Richard NH. Rihoux JP. Henocq E: Inhibitory effect of cetirizine 2. HC on eosinophil migration in vivo. Clin Allergy 1987:17: 373-379.
8. Michel L, De Vos C, Rihoux JP, Burtin C, Benveniste J, Dubertret L: Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. J Allergy Clin Immunol 1988:82:101-109.
9. Charlesworth EN, Sobotka K, Norman PS, Lichtenstein LM: Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 1989:83:905-912.
10. Tamura N, Agrawal DK, Suliaman FA, Town- ley RG: Effect of platelet-activating factor of the chemotaxis of normodense eosinophils from normal subjects. Biochem Biophvs Res Commun 1987:142:638-644.
11. Tamura N, Agrawal DK, Townley RG: Leukotriene C4 production from human eosinophils in vitro: Role of eosinophil chemotactic factors on eosinophil activation. J Immunol 1988:141:4291-4297.
12. Pick E, Mizel D: Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Meth 1981:46:211-215.
13. Sedgwick JB, Virtis RS. Gourley MF, Bussc WW: Stimulus-dependent differences in superoxide anion generation by normal human eosinophils and neutrophils. J Allergy Clin Immunol 1988:81:876-883.
14. Strath M, Warren DJ, Sanderson CJ: Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factor. J Immunol Meth 1985: 83:209-215.
15. Kroegel C, Yukawa T, Dent G, Venge P, Chung KF, Barnes PJ: Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol 1989:142:3518-3526.
16. Massey WA. Charlesworth EN, Sobotka AK. Norman PS, Lichtenstein LM: Cetirizine blocks granulocyte influx into allergic late phase reaction site. J Allergy Clin Immunol 1990;85(pt 2):214.
17. Fadal R, David B, Herpin-Richard N, Bougnon A, Rassemont R, Rihoux JP: In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in man. J Allergy Clin Immunol 1990:86:314-320.
18. Naclerio RM, Proud D, Sobotka AK. Feindhoff L. Norman PS, Lichtenstein LM: The effect of cetirizine on early allergic response. Laryngoscope 1989:99:586-599.
19. De Vos C, Michel J, Leprevost C, Vorng H, Tomassini M, Capron M, Capron A: Inhibition of human eosinophil chcmotaxis and of the IgE-dependent stimulation of human blood platelets by cetirizine. Int Arch Allergy Appl Immunol 1989:88:212-215.
20. Kyan-Aung U, Hallsworth M, Haskard D, De Vos C, Lee TH: The effects of ceterizine on the adhesion of human eosinophils and neutrophils to cultured human umbilical vein endothelial cells. J Allergy Clin Immunol 1992: 90:270-272.
21. Van Epps DE, Kutvirt SG, Potter JW: In vitro effects of cetirizine and histamine on human neutrophil function. Ann Allergy 1987:59 (pt 2): 13-19.
22. Jinquan T, Zachariae C, Simonsen C, Thestrup-Pedersen K: The effect of an H1 blocker, cetirizine dihydrochloride, on chemotaxis of subpopulations of leukocytes. J Allergy Clin Immunol 1991:87(pt 2):285.
23. Walsh GM, Mogbel R. Hartnell A, Kay AB: Effects of cetirizine on human eosinophil and neutrophil activation in vitro. Int Arch Allergy Appl Immunol 1991:95:158-162.
24. Bierman CW, Maxwell D, Rytina E, Emanuel MB. Lee TH: Effect of H1receptor blockade on late cutaneous reactions to antigen: A double-blind. controlled study. J Allergy Clin Immunol 1991:87:1013-1019.
25. Atkns P, Green GR, Zweiman B: Histologic studies of human skin test responses to ragweed, compound 48/80, and histamine. J Allergy 1973:51:263-273.
26. Wood SG, John BA, Chasseand LE, Yeh J, Chung M: The metabolism and pharmacokinetics of l4C-cetirizine in humans. Ann Allergy 1987:59 (pt 2):31-34.
27. Eda R, Sugiyama H, Hopp RJ, Bewtra AK, Townley RG: Effect of loratadine on human eosinophil function in vitro. Ann Allergy 1993:71:373-378.